AAAAAA
Results:
1-19
|
Results: 19
Authors:
Bernhard, D
Skvortsov, S
Tinhofer, I
Hubl, H
Greil, R
Csordas, A
Kofler, R
Citation: D. Bernhard et al., Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts, CELL DEAT D, 8(10), 2001, pp. 1014-1021
Authors:
Holzner, B
Kemmler, G
Sperner-Unterweger, B
Kopp, M
Dunser, M
Margreiter, R
Marschitz, I
Nachbaur, D
Fleischhacker, WW
Greil, R
Citation: B. Holzner et al., Quality of life measurement in oncology - a matter of the assessment instrument?, EUR J CANC, 37(18), 2001, pp. 2349-2356
Authors:
Greil, R
Citation: R. Greil, ESMO Recommendations for the application of haematopoietic growth factors (hGFs), ANN ONCOL, 12(9), 2001, pp. 1219-1220
Authors:
Duhmke, E
Franklin, J
Pfreundschuh, M
Sehlen, S
Willich, N
Ruhl, U
Muller, RP
Lukas, P
Atzinger, A
Paulus, U
Lathan, B
Ruffer, U
Sieber, M
Wolf, J
Engert, A
Georgii, A
Staar, S
Herrmann, R
Beykirch, M
Kirchner, H
Emminger, A
Greil, R
Fritsch, E
Koch, P
Drochtert, A
Brosteanu, O
Hasenclever, D
Loeffler, M
Diehl, V
Citation: E. Duhmke et al., Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone, J CL ONCOL, 19(11), 2001, pp. 2905-2914
Authors:
Krugmann, J
Dirnhofer, S
Gschwendtner, A
Berresheim, U
Greil, R
Krugmann, K
Fend, F
Citation: J. Krugmann et al., Primary gastrointestinal B-cell lymphoma - A clinicopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters, PATH RES PR, 197(6), 2001, pp. 385-393
Authors:
Stadlmann, S
Fend, F
Moser, P
Obrist, P
Greil, R
Dirnhofer, S
Citation: S. Stadlmann et al., Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type ofthe hypopharynx, in a renal allograft recipient: Case report and review ofliterature, HUMAN PATH, 32(11), 2001, pp. 1264-1268
Authors:
Bernhard, D
Tinhofer, I
Tonko, M
Hubl, H
Ausserlechner, MJ
Greil, R
Kofler, R
Csordas, A
Citation: D. Bernhard et al., Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells, CELL DEAT D, 7(9), 2000, pp. 834-842
Authors:
Marschitz, I
Tinhofer, I
Hittmair, A
Eagle, A
Kos, M
Greil, R
Citation: I. Marschitz et al., Analysis of Bcl-2 protein expression in chronic lymphocytic leukemia - A comparison of three semiquantitation techniques, AM J CLIN P, 113(2), 2000, pp. 219-229
Authors:
Krajnik, G
Mohn-Staudner, A
Thaler, J
Greil, R
Schmeikal, S
Marhold, F
Deutsch, J
Preiss, P
Malayeri, R
Schafer-Prokop, C
Wein, W
Huber, H
Pirker, R
Citation: G. Krajnik et al., Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): AnAASLC phase II trial, ANN ONCOL, 11(8), 2000, pp. 993-998
Authors:
Tinhofer, I
Wykypiel, H
Marschitz, I
Henn, T
Greil, R
Citation: I. Tinhofer et al., Gastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway, GUT, 46(5), 2000, pp. 738-739
Authors:
Tinhofer, I
Marschitz, I
Henn, T
Egle, A
Greil, R
Citation: I. Tinhofer et al., Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma, BLOOD, 95(2), 2000, pp. 610-618
Authors:
Rosenfield, JA
Todd, T
Greil, R
Citation: Ja. Rosenfield et al., Asymmetric hybridization and introgression between pink salmon and chinooksalmon in the Laurentian Great Lakes, T AM FISH S, 129(3), 2000, pp. 670-679
Authors:
Greil, R
Holzner, B
Kemmler, G
Kopp, M
Buchowski, A
Oberaigner, W
Fritsch, E
Dirnhofer, S
Rueffer, U
Diehl, V
Sperner-Unterweger, B
Citation: R. Greil et al., Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994, EUR J CANC, 35(5), 1999, pp. 698-706
Authors:
Kemmler, G
Holzner, B
Kopp, M
Dunser, M
Margreiter, R
Greil, R
Sperner-Unterweger, B
Citation: G. Kemmler et al., Comparison of two quality-of-life instruments for cancer patients: The functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30, J CL ONCOL, 17(9), 1999, pp. 2932-2940
Authors:
Krugmann, J
Feichtinger, H
Greil, R
Fend, F
Citation: J. Krugmann et al., Thymic Hodgkin's disease - A histological and immunohistochemical study ofthree cases, PATH RES PR, 195(10), 1999, pp. 681-687
Authors:
Villunger, A
Ghaffari-Tabrizi, N
Tinhofer, I
Krumbock, N
Bauer, B
Schneider, T
Kasibhatla, S
Greil, R
Baier-Bitterlich, G
Uberall, F
Green, DR
Baier, G
Citation: A. Villunger et al., Synergistic action of protein kinase C theta and calcineurin is sufficientfor Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells, EUR J IMMUN, 29(11), 1999, pp. 3549-3561
Authors:
Greil, R
Egle, A
Villunger, A
Citation: R. Greil et al., On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model, LEUK LYMPH, 31(5-6), 1998, pp. 477
Authors:
Krajnik, G
Wein, W
Greil, R
Marhold, F
Mohn-Staudner, A
Kummer, F
Malayeri, R
Zochbauer-Muller, S
Huber, H
Pirker, R
Citation: G. Krajnik et al., Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial, EUR J CANC, 34(12), 1998, pp. 1977-1980
Authors:
Greil, R
Citation: R. Greil, Application of hematopoietic growth factors for treatment of hematologic and oncologic diseases, ONKOLOGIE, 21(6), 1998, pp. 527-532
Risultati:
1-19
|